NSE - Delayed Quote INR

TTK Healthcare Limited (TTKHLTCARE.NS)

Compare
1,498.95 +45.00 (+3.10%)
At close: November 29 at 3:30 PM GMT+5:30
Loading Chart for TTKHLTCARE.NS
DELL
  • Previous Close 1,453.95
  • Open 1,460.00
  • Bid --
  • Ask --
  • Day's Range 1,455.00 - 1,507.95
  • 52 Week Range 1,310.15 - 1,893.95
  • Volume 5,805
  • Avg. Volume 10,690
  • Market Cap (intraday) 21.181B
  • Beta (5Y Monthly) 0.65
  • PE Ratio (TTM) 26.53
  • EPS (TTM) 56.51
  • Earnings Date Jan 31, 2025 - Feb 4, 2025
  • Forward Dividend & Yield 10.00 (0.67%)
  • Ex-Dividend Date Jul 16, 2024
  • 1y Target Est --

TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, Human Pharma, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, anti-parasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment is involved in the marketing and distribution of baby care products under the Woodward's Gripewater name; personal care products and cosmetics under the EVA name; home care products, such as scrubbers under the Good Home name; and air fresheners. The Medical Devices segment manufactures and markets artificial heart valves under the TTK Chitra name, as well as orthopedic implants and instruments for knee and hip replacements. The Protective Devices segment manufactures and markets sexual wellness products, including male contraceptives under the Skore brand name, and other allied products. The Foods segment engages in the manufacturing and marketing of food products, including papads under the Fryums name; and cereal, potato, rice, pulses, and corn-based products. The Human Pharma is involved in the development and commercialization of such as gynecology, infertility, respiratory, orthopedics, cardiology, and general health therapeutic needs. The Others segment prints and publishes maps, atlases, guidebooks, and educational publications under the TTK brand name. The company was founded in 1928 and is headquartered in Chennai, India. TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.

www.ttkhealthcare.com

1,316

Full Time Employees

March 31

Fiscal Year Ends

Recent News: TTKHLTCARE.NS

View More

Performance Overview: TTKHLTCARE.NS

Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

TTKHLTCARE.NS
6.50%
S&P BSE SENSEX
10.47%

1-Year Return

TTKHLTCARE.NS
10.96%
S&P BSE SENSEX
20.60%

3-Year Return

TTKHLTCARE.NS
129.02%
S&P BSE SENSEX
39.74%

5-Year Return

TTKHLTCARE.NS
198.73%
S&P BSE SENSEX
94.02%

Compare To: TTKHLTCARE.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TTKHLTCARE.NS

View More

Valuation Measures

Annual
As of 11/29/2024
  • Market Cap

    21.16B

  • Enterprise Value

    12.06B

  • Trailing P/E

    26.50

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.76

  • Price/Book (mrq)

    2.04

  • Enterprise Value/Revenue

    1.57

  • Enterprise Value/EBITDA

    10.10

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.36%

  • Return on Assets (ttm)

    1.14%

  • Return on Equity (ttm)

    7.95%

  • Revenue (ttm)

    7.71B

  • Net Income Avi to Common (ttm)

    799.43M

  • Diluted EPS (ttm)

    56.51

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.93B

  • Total Debt/Equity (mrq)

    3.00%

  • Levered Free Cash Flow (ttm)

    -1.12B

Research Analysis: TTKHLTCARE.NS

View More

Company Insights: TTKHLTCARE.NS

Research Reports: TTKHLTCARE.NS

View More

People Also Watch